Dr. Y. Cem Kaplan

Medical advisor, Flo Health Inc., Germany
Work Experience: 15+ years in clinical pharmacology and research

“My goal in medicine has always been to empower people to take care of their health by translating medical knowledge into individually tailored information — and healthtech is the perfect place to accomplish this. Knowing that I help to break medical stigmas and make an impact on people’s well-being is what drives me in my daily work.”

Career Highlights

  • Medical advisor at Flo Health Inc., Berlin, Germany, 2022–present
  • Medical quality specialist at Ada Health, Berlin, Germany, 2021–2022
  • Medical knowledge engineer at Ada Health, Berlin, Germany, 2019–2021
  • Professor of pharmacology at Izmir Katip Celebi (IKC) University, Izmir, Turkey, 2011–2019
  • Physician and head consultant in clinical pharmacology and toxicology, IKC University Ataturk Training and Research Hospital, Turkey, 2011–2019
  • Founder, director, and lead researcher, Izmir Teratology Information and Research Center, Turkey, 2011–2019
  • Visiting researcher for the Motherisk program, The Hospital for Sick Children, Toronto, Canada, 2014–2015
  • Associate head of the Non-Interventional Studies Review Board, IKC University, Izmir, Turkey, 2011–2012
  • Associate editor for Frontiers in Psychiatry for the Perinatal Psychiatry Section, 2022  
  • Editorial board member for BMC Pregnancy and Childbirth, 2020–2022
  • Scientific committee member for the European Network of Teratology Information Services, 2019–2020
  • Author of over 60 peer-reviewed papers, the majority of which focus on pregnancy and breastfeeding


  • Fellowship at The Hospital for Sick Children, Motherisk program, Toronto, Canada, 2014–2015
  • Degree in clinical pharmacology and toxicology from Dokuz Eylul University, Izmir, Turkey, 2007
  • Medical degree from Hacettepe University, Ankara, Turkey, 2002

Featured Publications

  • “Use of Phenytoin, Phenobarbital Carbamazepine, Levetiracetam Lamotrigine and Valproate in Pregnancy and Breastfeeding: Risk of Major Malformations, Dose-dependency, Monotherapy vs Polytherapy, Pharmacokinetics and Clinical Implications.” Current Neuropharmacology, vol. 19, no. 11, 2021, pp. 1805–1824. doi: 10.2174/1570159X19666210211150856.
  • “Ondansetron in Pregnancy Revisited: Assessment and Pregnancy Labelling by the European Medicines Agency (EMA) & Pharmacovigilance Risk Assessment Committee (PRAC).” Basic & Clinical Pharmacology & Toxicology, vol. 128, no. 4, Apr. 2021, pp. 579–582. doi: 10.1111/bcpt.13541.
  • “Use of Ondansetron during Pregnancy and the Risk of Major Congenital Malformations: A Systematic Review and Meta-Analysis.” Reproductive Toxicology, vol. 86, June 2019, pp. 1–13. doi: 10.1016/j.reprotox.2019.03.001.
  • “Maternal β-Blocker Use and Fetal Cardiac Anomalies.” JAMA Internal Medicine, vol. 177, no. 11, Nov. 2017, pp. 1692. doi: 10.1001/jamainternmed.2017.4894.
  • “Maternal SSRI Discontinuation, Use, Psychiatric Disorder and the Risk of Autism in Children: A Meta-Analysis of Cohort Studies.” British Journal of Clinical Pharmacology, vol. 83, no. 12, Dec. 2017, pp. 2798–2806. doi: 10.1111/bcp.13382.

My Journey in Medicine

After completing my medical degree, I chose to specialize in pharmacology because it’s an innovative field that inspires open thinking and the testing of new hypotheses. 

For eight years, I held a professorship position at IKC University in Turkey, where I founded and directed the Teratology Information and Research Center. Together with my team, we held hundreds of counseling sessions with reproductive-aged women and women with chronic diseases on the topic of medication during pregnancy and while breastfeeding. Working in and contributing knowledge to the burgeoning field of women’s health has always given me great satisfaction. In this role, I enjoyed being able to empower women with information on their treatment choices.

In my clinical work, I aimed to impact people’s health via digital tools. I helped my hospital build a clinical decision support system regarding drug-drug interactions in electronic prescriptions and a hospital pharmacy inventory to prevent shortages of critical medications. I also maintained a blog called “Farmafil,” where I wrote patient-friendly articles on medications.  

My journey in healthtech began when I joined Ada Health as a medical knowledge engineer. I then became a medical quality specialist, helping identify key health risks and prepare test plans for new products, features, deals, and settings.  

It’s very exciting to join Flo as a medical advisor. I feel fully aligned with Flo’s core mission to empower users to prioritize their health and am amazed by the huge impact we can make through the app. I also value the innovation mindset at the company and enjoy using my medical expertise to help develop new features and improve the user experience.

Fun Facts

During my professorship, my students nicknamed me “Fed” (federal agent) because I was frequently rolling up my shirt sleeves while giving lectures.

Flo Advisory Board of 100+ Doctors, Scientists, and Health Experts

We break down complex medical topics into accessible and digestible information that empowers readers to take action and prioritize their own well-being. Our team of Medical and Scientific Advisors is made up of over 100 certified health experts from a variety of disciplines who ensure that every piece of content we release is medically accurate, understandable, and up-to-date with the latest scientific findings. We rely on medical guidelines from international health organizations and get information from academic institutions and peer-reviewed articles, which is fully described in our Flo Editorial Process and Standards.